Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries.
Saved in:
| Title: | Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries. |
|---|---|
| Authors: | Bots SH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Riera-Arnau J; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain., Belitser SV; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Messina D; Agenzia Regionale di Sanitá, Florence, Toscana, Italy., Aragón M; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Alsina E; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain., Douglas IJ; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom., Durán CE; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain., García-Poza P; Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain., Gini R; Agenzia Regionale di Sanitá, Florence, Toscana, Italy., Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands., Huerta C; Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain., Sisay MM; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain., Martín-Pérez M; Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain., Martin I; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain., Overbeek JA; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands., Paoletti O; Agenzia Regionale di Sanitá, Florence, Toscana, Italy., Pallejà-Millán M; Unitat de Suport a la Recerca Tarragona-Reus, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Schultze A; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom., Souverein P; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Swart KMA; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands., Villalobos F; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain., Klungel OH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Sturkenboom MCJM; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 Nov 24; Vol. 13, pp. 1038043. Date of Electronic Publication: 2022 Nov 24 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36506571 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bots+SH%22">Bots SH</searchLink>; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Riera-Arnau+J%22">Riera-Arnau J</searchLink>; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Belitser+SV%22">Belitser SV</searchLink>; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Messina+D%22">Messina D</searchLink>; Agenzia Regionale di Sanitá, Florence, Toscana, Italy.<br /><searchLink fieldCode="AU" term="%22Aragón+M%22">Aragón M</searchLink>; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alsina+E%22">Alsina E</searchLink>; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Douglas+IJ%22">Douglas IJ</searchLink>; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Durán+CE%22">Durán CE</searchLink>; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García-Poza+P%22">García-Poza P</searchLink>; Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gini+R%22">Gini R</searchLink>; Agenzia Regionale di Sanitá, Florence, Toscana, Italy.<br /><searchLink fieldCode="AU" term="%22Herings+RMC%22">Herings RMC</searchLink>; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Huerta+C%22">Huerta C</searchLink>; Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sisay+MM%22">Sisay MM</searchLink>; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Martín-Pérez+M%22">Martín-Pérez M</searchLink>; Spanish Agency for Medicines and Medical Devices (AEMPS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martin+I%22">Martin I</searchLink>; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Overbeek+JA%22">Overbeek JA</searchLink>; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Paoletti+O%22">Paoletti O</searchLink>; Agenzia Regionale di Sanitá, Florence, Toscana, Italy.<br /><searchLink fieldCode="AU" term="%22Pallejà-Millán+M%22">Pallejà-Millán M</searchLink>; Unitat de Suport a la Recerca Tarragona-Reus, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Schultze+A%22">Schultze A</searchLink>; Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Souverein+P%22">Souverein P</searchLink>; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Swart+KMA%22">Swart KMA</searchLink>; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Villalobos+F%22">Villalobos F</searchLink>; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Klungel+OH%22">Klungel OH</searchLink>; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Sturkenboom+MCJM%22">Sturkenboom MCJM</searchLink>; Department of Datascience and Biostatistics, Julius Center for Health Sciences and Primary Health, University Medical Center Utrecht, Utrecht, Netherlands.; Clinical Pharmacology Service, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2022 Nov 24; Vol. 13, pp. 1038043. <i>Date of Electronic Publication: </i>2022 Nov 24 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36506571 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2022.1038043 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1038043 Titles: – TitleFull: Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bots SH – PersonEntity: Name: NameFull: Riera-Arnau J – PersonEntity: Name: NameFull: Belitser SV – PersonEntity: Name: NameFull: Messina D – PersonEntity: Name: NameFull: Aragón M – PersonEntity: Name: NameFull: Alsina E – PersonEntity: Name: NameFull: Douglas IJ – PersonEntity: Name: NameFull: Durán CE – PersonEntity: Name: NameFull: García-Poza P – PersonEntity: Name: NameFull: Gini R – PersonEntity: Name: NameFull: Herings RMC – PersonEntity: Name: NameFull: Huerta C – PersonEntity: Name: NameFull: Sisay MM – PersonEntity: Name: NameFull: Martín-Pérez M – PersonEntity: Name: NameFull: Martin I – PersonEntity: Name: NameFull: Overbeek JA – PersonEntity: Name: NameFull: Paoletti O – PersonEntity: Name: NameFull: Pallejà-Millán M – PersonEntity: Name: NameFull: Schultze A – PersonEntity: Name: NameFull: Souverein P – PersonEntity: Name: NameFull: Swart KMA – PersonEntity: Name: NameFull: Villalobos F – PersonEntity: Name: NameFull: Klungel OH – PersonEntity: Name: NameFull: Sturkenboom MCJM IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 11 Text: 2022 Nov 24 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |
